We are live on
!
Find out more
MLICM
Metropolitan Life Insurance Company (MetLife) Portfolio holdings
AUM
$328M
1-Year Est. Return
9.77%
This Fund
S&P 500
This Quarter
Est. Return
+4.37%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$7.53B
AUM Growth
-$8.45B
(-53%)
Cap. Flow
-$9.27B
Cap. Flow
% of AUM
-123.16%
Top 10 Holdings %
Top 10 Hldgs %
33.43%
Holding
2,587
New
127
Increased
54
Reduced
2,293
Closed
88
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$11.4M |
| 2 |
American Electric Power
AEP
|
+$5.7M |
| 3 |
BPMP
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
|
+$4.35M |
| 4 |
Clorox
CLX
|
+$3.38M |
| 5 |
KLA
KLAC
|
+$3.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$277M |
| 2 |
Bank of America
BAC
|
+$216M |
| 3 |
Microsoft
MSFT
|
+$202M |
| 4 |
Amazon
AMZN
|
+$140M |
| 5 |
Meta Platforms (Facebook)
META
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 29.11% |
| 2 | Technology | 11.55% |
| 3 | Healthcare | 8.57% |
| 4 | Industrials | 7.86% |
| 5 | Consumer Discretionary | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Spectrum Brands
SPB
$2.09B
| $203K | ﹤0.01% |
1,804
-17
| -0.9% | -$1.86K |
|
|
PF
1902
DELISTED
Pinnacle Foods, Inc.
PF
| $203K | ﹤0.01% |
3,415
-128
| -4% | -$7.21K |
|
1903
ATN International
ATNI
$491M
| $202K | ﹤0.01% |
3,662
-3,440
| -48% | -$188K |
|
|
CWEN.A
1904
DELISTED
Clearway Energy Class A
CWEN.A
| $202K | ﹤0.01% |
10,702
-13,346
| -55% | -$251K |
|
1905
UNIFI
UFI
$120M
| $202K | ﹤0.01% |
5,632
-5,929
| -51% | -$214K |
|
|
CARB
1906
DELISTED
Carbonite Inc
CARB
| $201K | ﹤0.01% |
8,016
-8,806
| -52% | -$204K |
|
1907
Lantheus
LNTH
$6.59B
| $200K | ﹤0.01% |
9,767
-9,179
| -48% | -$187K |
|
1908
Onto Innovation
ONTO
$20.6B
| $200K | ﹤0.01% |
8,010
-9,750
| -55% | -$260K |
|
|
VIVO
1909
DELISTED
Meridian Bioscience Inc
VIVO
| $200K | ﹤0.01% |
14,301
-17,444
| -55% | -$255K |
|
1910
Armstrong World Industries
AWI
$7.68B
| $199K | ﹤0.01% |
3,293
-31
| -0.9% | -$1.71K |
|
1911
Gogo Inc
GOGO
$377M
| $199K | ﹤0.01% |
17,605
-61,353
| -78% | -$653K |
|
|
EPZM
1912
DELISTED
Epizyme, Inc
EPZM
| $199K | ﹤0.01% |
15,871
-14,809
| -48% | -$215K |
|
|
STAY
1913
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $199K | ﹤0.01% |
10,457
-166
| -2% | -$3.09K |
|
|
TOWR
1914
DELISTED
Tower International, Inc.
TOWR
| $199K | ﹤0.01% |
6,499
-7,956
| -55% | -$240K |
|
1915
Stride
LRN
$3.48B
| $198K | ﹤0.01% |
+12,424
| New | +$207K |
|
|
FPRX
1916
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $198K | ﹤0.01% |
9,044
-10,289
| -53% | -$331K |
|
1917
AtriCure
ATRC
$2.21B
| $197K | ﹤0.01% |
10,781
-12,940
| -55% | -$256K |
|
1918
MBIA
MBI
$262M
| $197K | ﹤0.01% |
26,921
-55,470
| -67% | -$431K |
|
1919
CytomX Therapeutics
CTMX
$730M
| $196K | ﹤0.01% |
9,298
-7,878
| -46% | -$163K |
|
1920
HealthStream
HSTM
$849M
| $196K | ﹤0.01% |
8,476
-8,748
| -51% | -$206K |
|
1921
Rhythm Pharmaceuticals
RYTM
$7.99B
| $196K | ﹤0.01% |
+6,757
| New | +$179K |
|
1922
Westlake Corp
WLK
$10.2B
| $196K | ﹤0.01% |
1,844
-32
| -2% | -$2.96K |
|
|
RPXC
1923
DELISTED
RPX Corporation
RPXC
| $196K | ﹤0.01% |
14,590
-12,102
| -45% | -$160K |
|
|
LJPC
1924
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $196K | ﹤0.01% |
6,105
-6,339
| -51% | -$207K |
|
1925
AngioDynamics
ANGO
$647M
| $195K | ﹤0.01% |
11,730
-13,194
| -53% | -$225K |
|
Similar funds
GWM
KSCM
AFS
BAM
ML
BCM
ECH
PCM
Metropolitan Life Insurance Company (MetLife)'s Q4 2017 Portfolio in Review
As of Q4 2017, Metropolitan Life Insurance Company (MetLife) held 2,587 positions worth $7.53B, down 53% from $16B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Metropolitan Life Insurance Company (MetLife) withdrew a net $9.27B in Q4 2017, closing 88 positions and reducing 2,293 holdings. Its most notable exit was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $89.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 23% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Metropolitan Life Insurance Company (MetLife) opened a new position in CVS Health worth $11.4M.
- Metropolitan Life Insurance Company (MetLife)'s largest Q4 2017 buy was CVS Health: 157,105 shares worth $11.4M.
- Metropolitan Life Insurance Company (MetLife) added most to iShares National Muni Bond ETF in Q4 2017, an estimated $3M increase.
- Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2017 reduction was Apple, cutting an estimated $277M.
- Metropolitan Life Insurance Company (MetLife) fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2017, selling an estimated $89.8M.
- Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 33% of its $7.53B portfolio in Q4 2017.
- Metropolitan Life Insurance Company (MetLife) opened 127 new positions and closed 88 in Q4 2017.
- Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 53% quarter-over-quarter to $7.53B.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2017, filed 15 Feb 2018.